GleamWall
中文EN

LFST LifeStance Health Group, Inc.

Services-Health Services · Nasdaq · SEC CIK 1845257 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY22.6%
TTM net income YoY888.7%
TTM EPS YoY884.0%
Revenue 3-yr CAGR18.6%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin6.2%
Net margin4.3%
FCF margin10.7%
EBITDA margin8.8%

Returns

ROE4.8%
ROA3.3%
ROIC (approx.)5.4%
Asset turnover0.77x

Leverage & solvency

Liabilities / assets31.7%
Debt / equity0.18x
Current ratio1.44x
Interest coverage10.63x

Cash quality & payout

Operating cash flow / net income3.17x
Accruals ratio-7.2%
Payout ratio—
Capex / revenue2.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$1.42B$1.25B$1.06B$859.54M$667.51M
SG&A expense$382.20M$363.06M$410.79M$377.99M$433.73M
Operating income$24.15M-$31.61M-$189.13M-$210.17M-$286.35M
Interest expense$11.66M$26.54M$21.22M$19.93M$38.91M
Pretax income$12.36M-$57.61M-$206.58M-$232.73M-$333.11M
Income tax$2.70M-$170,000-$20.32M-$17.17M-$25.91M
Net income$9.66M-$57.44M-$186.26M-$215.56M-$307.20M
EBITDA$65.77M$9.06M-$151.76M-$181.26M-$271.26M
EPS (diluted)—————
Weighted avg. shares (diluted)391.14M379.15M367.46M355.28M327,523
Balance sheet
Cash & equivalents$248.64M$154.57M$78.82M$108.62M$148.03M
Receivables$95.71M$131.80M$125.41M$100.87M$76.08M
Current assets$416.20M$312.51M$225.73M$233.22M$266.52M
PP&E, net$161.58M$166.04M$188.22M$194.19M$152.24M
Goodwill$1.29B$1.29B$1.29B$1.27B$1.20B
Intangibles$177.66M$190.80M$221.07M$263.29M$300.36M
Total assets$2.20B$2.12B$2.11B$2.17B$1.93B
Current liabilities$251.96M$228.89M$202.87M$176.00M$116.75M
Short-term debt$14.50M$7.25M$2.92M$2.35M$1.32M
Long-term debt$265.93M$279.79M$280.29M$225.08M$157.42M
Total debt$280.43M$287.04M$283.21M$227.42M$158.74M
Total liabilities$682.92M$672.01M$681.04M$655.15M$382.08M
Shareholders' equity$1.52B$1.45B$1.43B$1.52B$1.55B
Net debt$31.79M$132.47M$204.39M$118.80M$10.71M
Shares outstanding388.32M382.74M378.73M375.96M374.25M
Cash flow statement
Operating cash flow$146.15M$107.26M-$16.88M$52.79M$9.42M
Capital expenditure$36.12M$21.57M$40.52M$79.25M$94.49M
Free cash flow$110.03M$85.69M-$57.40M-$26.47M-$85.07M
Investing cash flow-$36.12M-$21.57M-$60.34M-$139.46M-$194.08M
Financing cash flow-$15.96M-$9.95M$47.43M$47.26M$313.86M
Depreciation & amortization$41.62M$40.68M$37.37M$28.92M$15.09M
Stock-based compensation$74.70M$76.17M$99.39M$187.43M$259.44M

Free plan shows the latest 5 periods; Pro shows all 6 🔒

· This company does not report gross profit in XBRL.

· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.